Publicaciones en colaboración con investigadores/as de Hospital Universitario La Paz (11)

2024

  1. A randomised trial of short- vs long-term androgen deprivation with salvage radiotherapy for biochemical failure following radical prostatectomy: URONCOR 06-24

    BJU International, Vol. 134, Núm. 4, pp. 568-577

  2. Is trimodal therapy the current standard for muscle-invasive bladder cancer?

    Actas Urologicas Espanolas, Vol. 48, Núm. 5, pp. 345-355

2023

  1. Total neoadjuvant therapy for locally advanced rectal cancer: a narrative review

    Future oncology (London, England), Vol. 19, Núm. 25, pp. 1753-1768

2022

  1. Stereotactic body radiotherapy for early-stage non-small cell lung cancer: a multicentre study by the Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society)

    Clinical and Translational Oncology, Vol. 24, Núm. 2, pp. 342-349

  2. The Role of Prostate-specific Membrane Antigen Positron Emission Tomography/Magnetic Resonance Imaging in Primary and Recurrent Prostate Cancer: A Systematic Review of the Literature

    European Urology Focus, Vol. 8, Núm. 4, pp. 942-957

2021

  1. Are we at the end of adjuvant radiotherapy for prostate cancer?

    Actas Urologicas Espanolas

  2. Breast radiotherapy-related cardiotoxicity. When, how, why. risk prevention and control strategies

    Cancers, Vol. 13, Núm. 7

  3. Targeted therapy moves to earlier stages of non-small-cell lung cancer: Emerging evidence, controversies and future challenges

    Future Oncology, Vol. 17, Núm. 30, pp. 4011-4025

2020

  1. Clinical applications of molecular biomarkers in prostate cancer

    Cancers, Vol. 12, Núm. 6, pp. 1-25

  2. Genetic testing for the clinician in prostate cancer

    Expert Review of Molecular Diagnostics, Vol. 20, Núm. 9, pp. 933-946

  3. Immunotherapy moves to the early-stage setting in non-small cell lung cancer: Emerging evidence and the role of biomarkers

    Cancers, Vol. 12, Núm. 11, pp. 1-21